Replies to post #5078 on Mast Therapeutics, Inc. (MSTX)

[pnnymn]

from what i have gathered from others this author was also short on DNDN.

[Kobester]

The guy has never written a positive article about anything, ever so don't worry about it.

Today will allow us to do two things:
-Fill the .35 gap, which we had to do anyway before the next run
-Buy more cheap shares

I wasn't looking to get rich overnight so I'll continue to accumulate cheap shares, simple as that.

All IMO.

[DailyQuotes]

That's the most credible article I've seen written about ANX, and it's not looking too good.